Cingulate Inc. (CING)
NCM · Common · CUSIP 17248W105
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CING and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
17248W105
Market Cap
Micro Cap
Business: Cingulate Inc. is a clinical stage biopharmaceutical company using our proprietary Precision Timed Release, or PTR, drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.

Company Contact

CEO
Shane J. Schaffer
CFO
Jennifer Callahan
Headquarters
1901 W. 47th Place, Kansas City, KS 66205
Phone
913-942-2300
Investor Relations
Info@cingulate.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »